31 Mar 2021
Assets14.60
Total Income6.37
Profit After Tax0.46
NET Worth-0.23
Reserves and Surplus-0.24
Total Borrowing11.22
At a glance
Updated 2026-09-15Qualitek Labs is a SME IPO with an issue size of ₹19.64 crore, proposed for listing on BSE SME. The issue structure includes a fresh issue of ₹18.65 crore.
Issue details
Listing atBSE SME
Issue typeFixed Price Issue
Issue size₹19.64 Cr
Fresh issue₹18.65 Cr
Face value₹10
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure towards installation of plant and machinery for new & existing laboratories and for expansion of laboratories | ₹6.22 Cr |
| Repayment of unsecured loan to Promoter | ₹8.18 Cr |
| Funding of Working Capital Requirements | ₹2.50 Cr |
| General Corporate Purposes | ₹1.41 Cr |
| Issue Expenses | ₹1.33 Cr |
| Total | ₹19.64 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue12.51₹ Cr · -35.3% vs prior year
PAT2.01₹ Cr · -32.3% vs prior year
Assets44.10₹ Cr · +11.5% vs prior year
Net Worth11.87₹ Cr · +20.3% vs prior year
Borrowing25.00₹ Cr · +6.6% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2022
Assets22.20
Total Income12.02
Profit After Tax1.14
NET Worth1.90
Reserves and Surplus1.44
Total Borrowing17.29
31 Mar 2023
Assets39.56
Total Income19.35
Profit After Tax2.97
NET Worth9.87
Reserves and Surplus4.46
Total Borrowing23.45
30 Sep 2023
Assets44.10
Total Income12.51
Profit After Tax2.01
NET Worth11.87
Reserves and Surplus6.47
Total Borrowing25.00
KPIs
| KPI |
|---|
| ROE |
| ROCE |
| RoNW |
| PAT Margin |
| Price to Book Value |
Valuation & shareholding
Pre-IPO EPS5.49
Post-IPO EPS5.45
Pre-IPO P/E18.21
Post-IPO P/E18.34
Promoter holding pre99.99%
Promoter holding post73.35%
Market cap₹73.72 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Qualitek Labs IPO | — | 18.34 x | — | — |
| Pramodini Medicare IPO | — | 14.97 x | — | — |
| Invicta Diagnostic IPO | — | 21.68 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure towards installation of plant and machinery for new & existing laboratories and for expansion of laboratories | ₹6.22 Cr |
| Repayment of unsecured loan to Promoter | ₹8.18 Cr |
| Funding of Working Capital Requirements | ₹2.50 Cr |
| General Corporate Purposes | ₹1.41 Cr |
| Issue Expenses | ₹1.33 Cr |
| Total | ₹19.64 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Oneview Corporate Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-15.
IPO UPDATE ALERTS
Register for IPO Updates →Track Qualitek Labs without missing an update
Register for subscription, GMP, allotment and listing notifications.